直接抗病毒药物治疗失败后丙型肝炎病毒RNA水平:对低灵敏度诊断检测的影响
Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic Assays.
PubMed 文献 · Clin Infect Dis · 2020-01-01
该研究分析了直接抗病毒药物(DAA)临床试验中330例病毒学失败患者的治疗后HCV RNA水平。
要点
- 该水平高于简化监测用新型诊断检测的灵敏度下限。
- 提示低灵敏度检测或可用于DAA失败后的病毒学监测。
研究设计与样本
- 分析330例在直接抗病毒药物临床试验中发生病毒学失败受试者的治疗后HCV RNA水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We analyzed post-treatment hepatitis C virus (HCV) RNA levels from 330 subjects who experienced virologic failure in clinical trials of direct-acting antivirals. We demonstrated that 97% had post-treatment Week 12 HCV RNA >10 000 IU/mL, above reported sensitivity limits of novel diagnostic assays being considered for simplified HCV treatment monitoring.
来源:Clin Infect Dis,查看原文。版权归原作者所有。
引用
- Harrington PR, Komatsu TE, Sun H, et al. Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic Assays. Clin Infect Dis. 2020. PMID: 31075159. doi:10.1093/cid/ciz385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。